Miguel Ángel Rodríguez-Milla

2PUBLICATIONS
8CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 06, 2023
Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing.

Alvaro Morales-Molina, Miguel Ángel Rodriguez-Milla, Stefano Gambera

Pageof 1